Cargando…
The System Profile of Renal Drug Transporters in Tubulointerstitial Fibrosis Model and Consequent Effect on Pharmacokinetics
With the widespread clinical use of drug combinations, the incidence of drug–drug interactions (DDI) has significantly increased, accompanied by a variety of adverse reactions. Drug transporters play an important role in the development of DDI by affecting the elimination process of drugs in vivo, e...
Autores principales: | Shi, Birui, Zhang, Yan, Huang, Baolin, Lin, Huiping, Zhou, Qiong, Wang, Yujue, Cai, Zheng, Liu, Menghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838889/ https://www.ncbi.nlm.nih.gov/pubmed/35163972 http://dx.doi.org/10.3390/molecules27030704 |
Ejemplares similares
-
Drug Transporters in the Kidney: Perspectives on Species Differences, Disease Status, and Molecular Docking
por: Zou, Wei, et al.
Publicado: (2021) -
Calponin Expression in Renal Tubulointerstitial Fibrosis Induced in Rats by Cisplatin
por: Yuasa, Takahiro, et al.
Publicado: (2014) -
The Hippo-Salvador signaling pathway regulates renal tubulointerstitial fibrosis
por: Seo, Eunjeong, et al.
Publicado: (2016) -
DsbA-L mediated renal tubulointerstitial fibrosis in UUO mice
por: Li, Xiaozhou, et al.
Publicado: (2020) -
Is the proximal tubule the focus of tubulointerstitial fibrosis?
por: Peng, Zhi, et al.
Publicado: (2023)